You are here: Industry Insights > Change

News List

Canada announces changes to lower medicine prices pharmaceutical-technology
August 13, 2019
The Government of Canada has made changes to its Patented Medicines Regulations, initially introduced in 1987, in a bid to lower prices of prescription medicines.
Lilly Announces Leadership Changes contractpharma
August 08, 2019
Adjustments in Corporate Business Development, Oncology R&D, and Managed Healthcare Services .
How pharma will profit from a warming planet europeanpharmaceuticalreview
August 07, 2019
Rising temperatures will likely accelerate the spread of vector-borne diseases, resulting in an increased demand for vaccines. European Pharmaceutical Review investigates a Morgan Stanley report on the pharmaceutical beneficiaries of climate change.
Accellix expands leadership team & announces name change biospectrumasia
July 29, 2019
The Company also announced recent major additions to its senior leadership team
PCI Readies for Growth with Upper Management Changes contractpharma
May 21, 2019
Roberts, Evans, Schroeder and Ritchie to lead new PCI initiatives.
Natoli Engineering Releases 2019/2020 Catalog for Premium Encapsulation Change Kits americanpharmaceuticalreview
April 19, 2019
Natoli Engineering, through its Carlisle Precision Encapsulation Parts subsidiary, has released their Premium Encapsulation Change Kits catalog for 2019/2020.
Rakuten Aspyrian changes name to Rakuten Medical biospectrumasia
March 04, 2019
This name more closely reflects the company's corporate purpose of creating a global biotechnology company integrating research and development with commercial operations.
Sanofi Announces Organizational Change americanpharmaceuticalreview
September 14, 2018
Sanofi announced it will change the organizational structure of two of its Global Business Units (GBU).
It Might Be a Bumpy Ride: Why Life Sciences Companies Should Consider Embracing the New Wave of Change fiercebiotech
June 11, 2018
Changes in technology and geopolitics, coupled with U.S. tax reform and new financial accounting standards, are colliding like weather systems to create possibly the biggest disruption in accounting and financial reporting for life sciences companies sinc